Search
| (ENZN) NASDAQ | |||
| Last Trade | 9.80 | ||
| Change(%) | ![]() | -0.01 | |
| Volume | 425209 | ||
| 2:34 PM - Mar 09, 2010 | |||
News
Enzon to Present at NewsMakers in the Biotech Industry Conference
Enzon to Release Second Quarter 2009 Earnings on Tuesday, August 4, 2009; Conference Call and Webcast to Follow
Enzon to Present at BMO Focus on Healthcare Conference
Enzon Enhances Governance with the Addition of a New Non-Executive Chairman and New Independent Director

Enzon Presents Clinical Data from HIF-1 Alpha Antagonist Study at ASCO
-- First specific HIF-1a inhibitor is well tolerated with early signs of clinical benefit--
Enzon to Present at 29th Annual Cowen and Company Conference
Enzon's New Oncaspar-IV™ Receives Orphan Drug Status in the EU
-- Improved version to expand global potential --
Enzon Reports Solid Second Quarter 2008 Results
-- Product revenues increase 17% --

Enzon to Release Second Quarter 2009 Earnings on Tuesday, August 4, 2009; Conference Call and Webcast to Follow
Enzon to Release Fourth Quarter 2008 Earnings on Thursday, February 19, 2009; Conference Call and Webcast to Follow
Enzon Pharmaceuticals to Add New Independent Director to Board
Enzon Initiates Second Phase 1 Study of Its HIF-1 Alpha Antagonist
